Ross S Firestone (Ross Firestone)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 16

Top Topics

Multiple Myeloma

Prognostic Factors

Ejection Fraction

Acute Lymphoblastic Leukemia

Top Venues

Blood cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Ross S Firestone, Nicholas D Socci, Tala Shekarkhand, Menglei Zhu, Wei Ge Qin, Malin L Hultcrantz, Sham Mailankody, Carlyn Rose Tan, Neha Korde, Alexander M Lesokhin, Hani Hassoun, Urvi A Shah, Kylee H Maclachlan, Sridevi Rajeeve, Heather J Landau, Michael Scordo, Gunjan L Shah, Oscar B Lahoud, Sergio A Giralt, Kazunori Murata, Saad Z Usmani, David J Chung
Antigen escape as a shared mechanism of resistance to BCMA-directed therapies in multiple myeloma. Blood 144 (4) (2024)
Anna J Howard, Isabel Concepcion, Alice X Wang, Issam S Hamadeh, Malin L Hultcrantz, Sham Mailankody, Carlyn Rose Tan, Neha Korde, Alexander M Lesokhin, Hani Hassoun, Urvi A Shah, Kylee H Maclachlan, Sridevi Rajeeve, Heather J Landau, Michael Scordo, Gunjan L Shah, Oscar B Lahoud, David J Chung, Sergio A Giralt, Saad Z Usmani, Ross S Firestone
Unscheduled health care interactions in patients with multiple myeloma receiving T-cell redirection therapies. Blood advances 8 (12) (2024)
Issam S Hamadeh, Tala Shekarkhand, Colin Joseph Rueda, Ross S Firestone, Alice X Wang, Neha Korde, Malin L Hultcrantz, Alexander M Lesokhin, Sham Mailankody, Hani Hassoun, Urvi A Shah, Kylee H Maclachlan, Sridevi Rajeeve, Dhwani Patel, Gunjan L Shah, Michael Scordo, Oscar B Lahoud, David J Chung, Heather J Landau, Sergio A Giralt, Saad Z Usmani, Carlyn Rose Tan
Patterns of CRS with Teclistamab in Relapsed/Refractory Multiple Myeloma patients with Prior T-Cell Redirection Therapy. Blood advances (2024)
Anna J Howard, Isabel Concepcion, Alice X Wang, Issam S Hamadeh, Malin L Hultcrantz, Sham Mailankody, Carlyn Rose Tan, Neha Korde, Alexander M Lesokhin, Hani Hassoun, Urvi A Shah, Kylee H Maclachlan, Sridevi Rajeeve, Heather J Landau, Michael Scordo, Gunjan L Shah, Oscar B Lahoud, David J Chung, Sergio A Giralt, Saad Z Usmani, Ross S Firestone
Unscheduled health care interactions in patients with multiple myeloma receiving T-cell redirection therapies. Blood advances 8 (12) (2024)
Anna J Howard, Isabel Concepcion, Alice X Wang, Issam S Hamadeh, Malin L Hultcrantz, Sham Mailankody, Carlyn Rose Tan, Neha Korde, Alexander M Lesokhin, Hani Hassoun, Urvi A Shah, Kylee H Maclachlan, Sridevi Rajeeve, Heather J Landau, Michael Scordo, Gunjan L Shah, Oscar B Lahoud, David J Chung, Sergio A Giralt, Saad Z Usmani, Ross S Firestone
Unscheduled health care interactions in patients with multiple myeloma receiving T-cell redirection therapies. Blood advances 8 (12) (2024)
Ross S Firestone, Nicholas D Socci, Tala Shekarkhand, Menglei Zhu, Wei Ge Qin, Malin L Hultcrantz, Sham Mailankody, Carlyn Rose Tan, Neha Korde, Alexander M Lesokhin, Hani Hassoun, Urvi A Shah, Kylee H Maclachlan, Sridevi Rajeeve, Heather J Landau, Michael Scordo, Gunjan L Shah, Oscar B Lahoud, Sergio A Giralt, Kazunori Murata, Saad Z Usmani, David J Chung
Antigen escape as a shared mechanism of resistance to BCMA-directed therapies in multiple myeloma. Blood 144 (4) (2024)
Anna J Howard, Isabel Concepcion, Alice X Wang, Issam S Hamadeh, Malin L Hultcrantz, Sham Mailankody, Carlyn Rose Tan, Neha Korde, Alexander M Lesokhin, Hani Hassoun, Urvi A Shah, Kylee H Maclachlan, Sridevi Rajeeve, Heather J Landau, Michael Scordo, Gunjan L Shah, Oscar B Lahoud, David J Chung, Sergio A Giralt, Saad Z Usmani, Ross S Firestone
Unscheduled health care interactions in patients with multiple myeloma receiving T-cell redirection therapies. Blood advances 8 (12) (2024)
Issam S Hamadeh, Tala Shekarkhand, Colin Rueda, Ross S Firestone, Alice X Wang, Neha Korde, Malin L Hultcrantz, Alexander M Lesokhin, Sham Mailankody, Hani Hassoun, Urvi A Shah, Kylee H Maclachlan, Sridevi Rajeeve, Dhwani Patel, Gunjan L Shah, Michael Scordo, Oscar B Lahoud, David J Chung, Heather J Landau, Sergio A Giralt, Saad Z Usmani, Carlyn Rose Tan
Patterns of CRS with teclistamab in relapsed/refractory multiple myeloma with or without prior T-cell redirection therapy. Blood advances 8 (12) (2024)
Ross S Firestone, Nicholas D Socci, Tala Shekarkhand, Menglei Zhu, Wei Ge Qin, Malin L Hultcrantz, Sham Mailankody, Carlyn Rose Tan, Neha Korde, Alexander M Lesokhin, Hani Hassoun, Urvi A Shah, Kylee H Maclachlan, Sridevi Rajeeve, Heather J Landau, Michael Scordo, Gunjan L Shah, Oscar B Lahoud, Sergio A Giralt, Kazunori Murata, Saad Z Usmani, David J Chung
Antigen escape as a shared mechanism of resistance to BCMA-directed therapies in multiple myeloma. Blood (2024)
Issam S Hamadeh, Tala Shekarkhand, Colin Rueda, Ross S Firestone, Alice X Wang, Neha Korde, Malin L Hultcrantz, Alexander M Lesokhin, Sham Mailankody, Hani Hassoun, Urvi A Shah, Kylee H Maclachlan, Sridevi Rajeeve, Dhwani Patel, Gunjan L Shah, Michael Scordo, Oscar B Lahoud, David J Chung, Heather J Landau, Sergio A Giralt, Saad Z Usmani, Carlyn Rose Tan
Patterns of CRS with teclistamab in relapsed/refractory multiple myeloma with or without prior T-cell redirection therapy. Blood advances 8 (12) (2024)
Anna J Howard, Isabel Concepcion, Alice X Wang, Issam S Hamadeh, Malin L Hultcrantz, Sham Mailankody, Carlyn Rose Tan, Neha Korde, Alexander M Lesokhin, Hani Hassoun, Urvi A Shah, Kylee H Maclachlan, Sridevi Rajeeve, Heather J Landau, Michael Scordo, Gunjan L Shah, Oscar B Lahoud, David J Chung, Sergio A Giralt, Saad Z Usmani, Ross S Firestone
Unscheduled healthcare interactions in multiple myeloma patients receiving T cell redirection therapies. Blood advances (2024)
Ross S Firestone, Nicholas D Socci, Tala Shekarkhand, Menglei Zhu, Wei Ge Qin, Malin L Hultcrantz, Sham Mailankody, Carlyn Rose Tan, Neha Korde, Alexander M Lesokhin, Hani Hassoun, Urvi A Shah, Kylee H Maclachlan, Sridevi Rajeeve, Heather J Landau, Michael Scordo, Gunjan L Shah, Oscar B Lahoud, Sergio A Giralt, Kazunori Murata, Saad Z Usmani, David J Chung
Antigen escape as a shared mechanism of resistance to BCMA-directed therapies in multiple myeloma. Blood 144 (4) (2024)
Issam S Hamadeh, Tala Shekarkhand, Colin Rueda, Ross S Firestone, Alice X Wang, Neha Korde, Malin L Hultcrantz, Alexander M Lesokhin, Sham Mailankody, Hani Hassoun, Urvi A Shah, Kylee H Maclachlan, Sridevi Rajeeve, Dhwani Patel, Gunjan L Shah, Michael Scordo, Oscar B Lahoud, David J Chung, Heather J Landau, Sergio A Giralt, Saad Z Usmani, Carlyn Rose Tan
Patterns of CRS with teclistamab in relapsed/refractory multiple myeloma with or without prior T-cell redirection therapy. Blood advances 8 (12) (2024)
Ross S Firestone, Nicholas D Socci, Tala Shekarkhand, Menglei Zhu, Wei Ge Qin, Malin L Hultcrantz, Sham Mailankody, Carlyn Rose Tan, Neha Korde, Alexander M Lesokhin, Hani Hassoun, Urvi A Shah, Kylee H Maclachlan, Sridevi Rajeeve, Heather J Landau, Michael Scordo, Gunjan L Shah, Oscar B Lahoud, Sergio A Giralt, Kazunori Murata, Saad Z Usmani, David J Chung
Antigen escape as a shared mechanism of resistance to BCMA-directed therapies in multiple myeloma. Blood 144 (4) (2024)
Ross S Firestone, Alexander M Lesokhin, Saad Z Usmani
An Embarrassment of Riches: Three FDA-Approved Bispecific Antibodies for Relapsed Refractory Multiple Myeloma. Blood cancer discovery (2023)
Ross S Firestone, Devin McAvoy, Tala Shekarkhand, Edith Serrano, Issam Hamadeh, Alice Wang, Menglei Zhu, Dhwani Patel, Carlyn Rose Tan, Malin L Hultcrantz, Sham Mailankody, Hani Hassoun, Urvi A Shah, Neha Korde, Kylee H Maclachlan, Heather J Landau, Michael Scordo, Gunjan L Shah, Oscar B Lahoud, Sergio A Giralt, Kazunori Murata, Kinga K Hosszu, David J Chung, Alexander M Lesokhin, Saad Z Usmani
CD8 effector T cells enhance response in BCMA-exposed and -naïve multiple myeloma. Blood advances (2023)